CytoMed Therapeutics Price to Book Value Insights

CytoMed Therapeutics Ltd. (GDTC)

0.82 +0.03 (+3.18%) USD | NASDAQ | Sep 10, 16:00

0.82 0.00 (0.00%) After-Hours: 20:00

Price to Book Value Chart

View Price to Book Value for GDTC.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Price to Book Value Chart

Start Trial

Historical Price to Book Value Data

View and export this data back to . Start Trial.

Date	Value
September 10, 2026

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks

Start Trial

Arrowhead Pharmaceuticals, Inc.	25.10
Oncolytics Biotech, Inc.	--
Sangamo Therapeutics, Inc.	--
Sarepta Therapeutics, Inc.	1.419
Anixa Biosciences, Inc.	6.513

Price to Book Value Related Metrics

PS Ratio	38.51
Price	0.82
Earnings Yield	-31.84%
Market Cap	9.699M